v3.26.1
CONCENTRATION - Schedule of Operating Results (Details) - USD ($)
 3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting [Line Items]        
Sales $ 26,143 $ 56,148 $ 258,802 $ 287,213
Cost of Goods Sold 3,610 6,331 87,054 25,508
Gross Profit 22,533 49,817 171,748 261,705
Selling Expense 5,886 14,255 58,212 37,449
Anti-Aging & Immune Support [Member]        
Segment Reporting [Line Items]        
Sales 14,010 50,008 184,764 254,404
Cost of Goods Sold 1,226 5,858 64,286 22,505
Gross Profit 12,784 44,150 120,478 231,899
Selling Expense 628 13,363 17,600 33,855
Targeted System Support [Member]        
Segment Reporting [Line Items]        
Sales 9,655 6,140 55,286 32,809
Cost of Goods Sold 1,392 473 16,118 3,003
Gross Profit 8,263 5,667 39,168 29,806
Selling Expense 3,068 892 15,206 3,594
Herbal Insulin Support [Member]        
Segment Reporting [Line Items]        
Sales 2,478 0 18,752 0
Cost of Goods Sold 992 0 6,650 0
Gross Profit 1,486 0 12,102 0
Selling Expense $ 2,190 $ 0 $ 25,406 $ 0